Publication Information

{'id': 'https://openalex.org/W2994342338', 'doi': 'https://doi.org/10.1158/1535-7163.targ-19-c091', 'title': 'Abstract C091: Preclinical evaluation of PK, PD, and antitumor activity of the oral, non-covalent, potent and highly selective CDK7 inhibitor, SY-5609, provides rationale for clinical development in multiple solid tumor indications', 'display_name': 'Abstract C091: Preclinical evaluation of PK, PD, and antitumor activity of the oral, non-covalent, potent and highly selective CDK7 inhibitor, SY-5609, provides rationale for clinical development in multiple solid tumor indications', 'publication_year': 2019, 'publication_date': '2019-12-01', 'ids': {'openalex': 'https://openalex.org/W2994342338', 'doi': 'https://doi.org/10.1158/1535-7163.targ-19-c091', 'mag': '2994342338'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1535-7163.targ-19-c091', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S48437117', 'display_name': 'Molecular Cancer Therapeutics', 'issn_l': '1535-7163', 'issn': ['1535-7163', '1538-8514'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5047133226', 'display_name': 'Liv Johannessen', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Liv H Johannessen', 'raw_affiliation_strings': ['Syros Pharmaceuticals, Cambridge, MA.'], 'affiliations': [{'raw_affiliation_string': 'Syros Pharmaceuticals, Cambridge, MA.', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5058432610', 'display_name': 'Shanhu Hu', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Shanhu Hu', 'raw_affiliation_strings': ['Syros Pharmaceuticals, Cambridge, MA.'], 'affiliations': [{'raw_affiliation_string': 'Syros Pharmaceuticals, Cambridge, MA.', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5102922377', 'display_name': 'Nan Rosemary Ke', 'orcid': 'https://orcid.org/0009-0003-7647-8449'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Nan Ke', 'raw_affiliation_strings': ['Syros Pharmaceuticals, Cambridge, MA.'], 'affiliations': [{'raw_affiliation_string': 'Syros Pharmaceuticals, Cambridge, MA.', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5055542392', 'display_name': 'Anthony D’Ippolito', 'orcid': 'https://orcid.org/0000-0001-9245-762X'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': "Anthony D'Ippolito", 'raw_affiliation_strings': ['Syros Pharmaceuticals, Cambridge, MA.'], 'affiliations': [{'raw_affiliation_string': 'Syros Pharmaceuticals, Cambridge, MA.', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5032144639', 'display_name': 'Nisha Rajagopal', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Nisha Rajagopal', 'raw_affiliation_strings': ['Syros Pharmaceuticals, Cambridge, MA.'], 'affiliations': [{'raw_affiliation_string': 'Syros Pharmaceuticals, Cambridge, MA.', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5071463273', 'display_name': 'Jason Marineau', 'orcid': 'https://orcid.org/0000-0002-4321-0038'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Jason Marineau', 'raw_affiliation_strings': ['Syros Pharmaceuticals, Cambridge, MA.'], 'affiliations': [{'raw_affiliation_string': 'Syros Pharmaceuticals, Cambridge, MA.', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5056800538', 'display_name': 'Anneli Savinainen', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Anneli Savinainen', 'raw_affiliation_strings': ['Syros Pharmaceuticals, Cambridge, MA.'], 'affiliations': [{'raw_affiliation_string': 'Syros Pharmaceuticals, Cambridge, MA.', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5085654922', 'display_name': 'William C. Zamboni', 'orcid': 'https://orcid.org/0000-0002-8319-4482'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'William Zamboni', 'raw_affiliation_strings': ['Syros Pharmaceuticals, Cambridge, MA.'], 'affiliations': [{'raw_affiliation_string': 'Syros Pharmaceuticals, Cambridge, MA.', 'institution_ids': []}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5103621251', 'display_name': 'Graeme Hodgson', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Graeme Hodgson', 'raw_affiliation_strings': ['Syros Pharmaceuticals, Cambridge, MA.'], 'affiliations': [{'raw_affiliation_string': 'Syros Pharmaceuticals, Cambridge, MA.', 'institution_ids': []}]}], 'institution_assertions': [], 'countries_distinct_count': 0, 'institutions_distinct_count': 0, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.949, 'has_fulltext': False, 'cited_by_count': 8, 'citation_normalized_percentile': {'value': 0.8743, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 83, 'max': 84}, 'biblio': {'volume': '18', 'issue': '12_Supplement', 'first_page': 'C091', 'last_page': 'C091'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T12829', 'display_name': 'Advanced Breast Cancer Therapies', 'score': 0.9974, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T12829', 'display_name': 'Advanced Breast Cancer Therapies', 'score': 0.9974, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T12334', 'display_name': 'Lung Cancer Research Studies', 'score': 0.9614, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11914', 'display_name': 'PARP inhibition in cancer therapy', 'score': 0.9075, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/palbociclib', 'display_name': 'Palbociclib', 'score': 0.8518455}, {'id': 'https://openalex.org/keywords/fulvestrant', 'display_name': 'Fulvestrant', 'score': 0.81624454}, {'id': 'https://openalex.org/keywords/pharmacodynamics', 'display_name': 'Pharmacodynamics', 'score': 0.5534254}], 'concepts': [{'id': 'https://openalex.org/C2779744173', 'wikidata': 'https://www.wikidata.org/wiki/Q15269707', 'display_name': 'Palbociclib', 'level': 5, 'score': 0.8518455}, {'id': 'https://openalex.org/C2780482068', 'wikidata': 'https://www.wikidata.org/wiki/Q5508491', 'display_name': 'Fulvestrant', 'level': 5, 'score': 0.81624454}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.6160984}, {'id': 'https://openalex.org/C111113717', 'wikidata': 'https://www.wikidata.org/wiki/Q725307', 'display_name': 'Pharmacodynamics', 'level': 3, 'score': 0.5534254}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.48974848}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.48285633}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.48149288}, {'id': 'https://openalex.org/C112705442', 'wikidata': 'https://www.wikidata.org/wiki/Q323936', 'display_name': 'Pharmacokinetics', 'level': 2, 'score': 0.46561337}, {'id': 'https://openalex.org/C84606932', 'wikidata': 'https://www.wikidata.org/wiki/Q416496', 'display_name': 'Estrogen receptor', 'level': 4, 'score': 0.45756537}, {'id': 'https://openalex.org/C530470458', 'wikidata': 'https://www.wikidata.org/wiki/Q128581', 'display_name': 'Breast cancer', 'level': 3, 'score': 0.42061216}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.3120907}, {'id': 'https://openalex.org/C2775930923', 'wikidata': 'https://www.wikidata.org/wiki/Q12859063', 'display_name': 'Metastatic breast cancer', 'level': 4, 'score': 0.17048535}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1535-7163.targ-19-c091', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S48437117', 'display_name': 'Molecular Cancer Therapeutics', 'issn_l': '1535-7163', 'issn': ['1535-7163', '1538-8514'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.83, 'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W4379283690', 'https://openalex.org/W4232409591', 'https://openalex.org/W4206711305', 'https://openalex.org/W3216407617', 'https://openalex.org/W3161515104', 'https://openalex.org/W2982700532', 'https://openalex.org/W2947864495', 'https://openalex.org/W2897446380', 'https://openalex.org/W2892043300', 'https://openalex.org/W2605489431'], 'abstract_inverted_index': {'Abstract': [0], 'Introduction:': [1], 'CDK7': [2, 47, 408, 521], 'is': [3, 40, 50, 420], 'a': [4, 59, 157, 318, 356, 412, 463], 'key': [5], 'regulator': [6], 'of': [7, 58, 87, 134, 167, 230, 325, 381, 406, 414, 465, 477, 507, 513, 537], 'transcription': [8], 'and': [9, 13, 44, 79, 113, 127, 137, 174, 201, 211, 233, 285, 314, 327, 358, 371, 383, 403, 422, 439, 473, 510, 518, 545], 'cell': [10, 31, 93, 104], 'cycle': [11, 32, 94], 'progression': [12], 'has': [14], 'been': [15], 'implicated': [16], 'in': [17, 65, 84, 131, 162, 175, 181, 186, 222, 294, 368, 411, 418, 435, 445, 479, 529], 'multiple': [18, 450, 530], 'tumor': [19, 80, 88, 243, 336, 436, 452, 467, 532], 'types': [20, 89], 'driven': [21, 275], 'by': [22, 276], 'aberrant': [23, 30], 'transcriptional': [24, 91, 220, 433], 'control': [25, 33], '(e.g.': [26, 34], 'MYC-,': [27], 'ESR1-activation)': [28], 'and/or': [29, 92], 'RB1,': [35], 'CCNE1,': [36], 'CDKN2A': [37], 'alterations).': [38], 'SY-5609': [39, 124, 152, 205, 231, 290, 326, 350, 365, 382, 410, 430, 461, 478], 'an': [41], 'oral,': [42, 515], 'potent,': [43], 'highly': [45, 519], 'selective': [46, 520], 'inhibitor': [48, 193, 409], 'that': [49, 271], 'advancing': [51], 'through': [52], 'IND-enabling': [53], 'studies': [54], 'to': [55, 190, 198, 339, 395], 'support': [56, 474], 'initiation': [57], 'planned': [60], 'Phase': [61], '1': [62], 'oncology': [63], 'trial': [64], 'early': [66, 480], '2020.': [67], 'Here': [68], 'we': [69], 'report': [70], 'on': [71, 542], 'the': [72, 191, 250, 260, 272, 323, 346, 379, 407, 457, 475, 514, 538], 'relationship': [73, 122], 'between': [74, 123], 'pharmacokinetics': [75], '(PK),': [76], 'pharmacodynamics': [77], '(PD),': [78], 'growth': [81], 'inhibition': [82], '(TGI)': [83], 'xenograft': [85, 132, 164, 223, 415, 437], 'models': [86, 133, 166, 184, 296, 447], 'with': [90, 177, 242, 299, 333], 'aberrations': [95], 'including': [96, 443, 469], 'high': [97], 'grade': [98], 'serous': [99], 'ovarian': [100], 'cancer': [101, 106, 111, 118], '(HGSOC),': [102], 'small': [103], 'lung': [105], '(SCLC),': [107], 'triple': [108], 'negative': [109], 'breast': [110, 117], '(TNBC),': [112], 'estrogen': [114], 'receptor': [115], 'positive': [116], '(ER+BC).': [119], 'Methods:': [120], 'The': [121], 'PK,': [125, 401, 508], 'PD,': [126, 402, 509], 'TGI': [128, 153, 239, 256, 293, 307, 331, 370, 387], 'was': [129, 154, 208, 240, 257, 264, 274], 'evaluated': [130, 155], 'HGSOC': [135, 168], '(OVCAR3)': [136], 'TNBC': [138, 172, 286], '(HCC70)': [139], 'using': [140], 'once': [141, 178], 'daily': [142, 146, 262], '(QD)': [143], 'or': [144, 196, 268, 279, 308, 352], 'twice': [145], '(BID)': [147], 'dosing': [148, 232, 343], 'via': [149], 'oral': [150], 'gavage.': [151], 'as': [156], 'single': [158], 'agent': [159], '(SA)': [160], 'QD': [161, 267], 'patient-derived': [163], '(PDX)': [165], '(n=3),': [169], 'SCLC': [170], '(n=4),': [171, 173], 'combination': [176, 324, 380], 'weekly': [179], 'fulvestrant': [180, 202, 328, 353, 359, 372, 384, 391], 'ER+BC': [182, 320], 'PDX': [183, 287, 321, 363, 446], 'selected': [185], 'vivo': [187], 'for': [188, 236, 460, 526], 'resistance': [189, 197], 'CDK4/6': [192], 'palbociclib': [194, 200, 357], '(n=1)': [195], 'both': [199], '(n=1).': [203], 'Results:': [204], 'plasma': [206, 419], 'exposure': [207, 278], 'dose': [209, 253, 263, 428], 'proportional': [210], 'did': [212], 'not': [213, 424], 'accumulate': [214, 425], 'after': [215, 342], 'repeated': [216], 'therapeutic': [217, 427], 'doses.': [218], 'Dose-dependent': [219], 'responses': [221, 434], 'tissue': [224, 438], 'were': [225, 234], 'observed': [226, 245, 347], 'within': [227], '4': [228], 'hours': [229], 'sustained': [235], '24': [237], 'hours.': [238], 'dose-dependent,': [241], 'regressions': [244], 'at': [246, 426], 'doses': [247], 'significantly': [248], 'below': [249], 'maximum': [251], 'tolerated': [252], '(MTD).': [254], 'Similar': [255], 'seen': [258], 'when': [259], 'same': [261], 'administered': [265], 'either': [266], 'BID': [269], 'suggesting': [270, 393], 'effect': [273], 'overall': [277], 'minimum': [280], 'concentration.': [281], 'In': [282, 317, 355, 377], 'HGSOC,': [283, 311], 'SCLC,': [284, 313], 'models,': [288], 'SA': [289, 351, 366, 373], 'induced': [291, 329], '>50%': [292], 'all': [295], 'tested': [297], '(11/11),': [298], '7/11': [300], '(64%)': [301], 'demonstrating': [302], 'robust': [303, 441], 'anti-tumor': [304, 404], 'activity': [305, 405, 512], '(≥90%': [306], 'regression):': [309], '3/3': [310], '2/4': [312, 315], 'TNBC.': [316], 'palbociclib-resistant': [319], 'model,': [322, 364], 'significant': [330, 386], '(89%),': [332], 'no': [334, 375], 'evident': [335], 'regrowth': [337], 'up': [338], '21': [340], 'days': [341], 'cessation,': [344], 'distinguishing': [345], 'effects': [348], 'from': [349, 449], 'SA.': [354], 'double-resistant': [360], 'ER+': [361], 'BC': [362], 'resulted': [367], '33%': [369], 'had': [374], 'activity.': [376], 'contrast,': [378], 'demonstrated': [385], '(68%;': [388], 'p<0.0001': [389], 'vs': [390], 'SA),': [392], 're-sensitization': [394], 'fulvestrant.': [396], 'Conclusions:': [397], 'We': [398], 'have': [399], 'characterized': [400], 'series': [413], 'models.': [416], 'Exposure': [417], 'dose-proportional': [421], 'does': [423], 'levels.': [429], 'induces': [431], 'dose-dependent': [432], 'shows': [440], 'TGI,': [442], 'regressions,': [444], 'derived': [448], 'solid': [451, 466, 531], 'indications.': [453], 'These': [454], 'results': [455], 'highlight': [456], 'broad': [458], 'potential': [459], 'across': [462], 'variety': [464], 'types,': [468], 'treatment': [470], 'resistant': [471], 'ER+BC,': [472], 'development': [476, 528], 'phase': [481], 'clinical': [482, 527], 'trials.': [483], 'Citation': [484], 'Format:': [485], 'Liv': [486], 'H': [487], 'Johannessen,': [488], 'Shanhu': [489], 'Hu,': [490], 'Nan': [491], 'Ke,': [492], 'Anthony': [493], "D'Ippolito,": [494], 'Nisha': [495], 'Rajagopal,': [496], 'Jason': [497], 'Marineau,': [498], 'Anneli': [499], 'Savinainen,': [500], 'William': [501], 'Zamboni,': [502], 'Graeme': [503], 'Hodgson.': [504], 'Preclinical': [505], 'evaluation': [506], 'antitumor': [511], 'non-covalent,': [516], 'potent': [517], 'inhibitor,': [522], 'SY-5609,': [523], 'provides': [524], 'rationale': [525], 'indications': [533], '[abstract].': [534], 'In:': [535], 'Proceedings': [536], 'AACR-NCI-EORTC': [539], 'International': [540], 'Conference': [541], 'Molecular': [543], 'Targets': [544], 'Cancer': [546, 557], 'Therapeutics;': [547], '2019': [548], 'Oct': [549], '26-30;': [550], 'Boston,': [551], 'MA.': [552], 'Philadelphia': [553], '(PA):': [554], 'AACR;': [555], 'Mol': [556], 'Ther': [558], '2019;18(12': [559], 'Suppl):Abstract': [560], 'nr': [561], 'C091.': [562], 'doi:10.1158/1535-7163.TARG-19-C091': [563]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2994342338', 'counts_by_year': [{'year': 2024, 'cited_by_count': 1}, {'year': 2023, 'cited_by_count': 1}, {'year': 2022, 'cited_by_count': 2}, {'year': 2021, 'cited_by_count': 1}, {'year': 2020, 'cited_by_count': 2}], 'updated_date': '2025-01-14T23:40:00.816111', 'created_date': '2019-12-13'}